Pricing
  1. JP-listed companies
  2. Qol Holdings Co.,Ltd.
  3. Financials
  4. EBITDA margin (%)

Qol Holdings Co.,Ltd.【JP:3034】

Market cap
¥68.8B
P/E ratio
9.5x
Cure All Holdings operates pharmacies, provides business outsourcing services to pharmaceutical companies, and manufactures drugs to support healthcare across communities.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Mar 31, 20256.6+17.32%
Mar 31, 20245.6-14.04%
Mar 31, 20236.6-4.35%
Mar 31, 20226.9+24.33%
Mar 31, 20215.5-2.56%
Mar 31, 20205.7-6.34%
Mar 31, 20196.1-17.76%
Mar 31, 20187.4+14.61%
Mar 31, 20176.4-3.46%
Mar 31, 20166.7+30.01%
Mar 31, 20155.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)